Tornetta Mark A, Whitaker Brian P, Cantwell Olivia M, Haytko Peter N, Pisors Eileen D, Zhou Fulai, Chiu Mark L
Tavotek Biotherapeutics, 727 Norristown Road, Spring House Innovation Park, Building 3, Suite 101, Lower Gwynedd, PA 19002, USA.
Tavotek Biotherapeutics Building C2, Suzhou Biomedical Industrial Park, Suzhou 215000, China.
Antibodies (Basel). 2025 Aug 15;14(3):71. doi: 10.3390/antib14030071.
BACKGROUND/OBJECTIVES: The complexity of diseases such as cancer and auto-immune disorders drives the need for unique, target-driven therapeutics. A broader arsenal to generate better biologics-based therapeutics is needed to provide more efficient and effective antibody generation technologies. The critical parameter for antibody generation is to generate as much candidate diversity to each target as possible.
METHOD/RESULTS: We present guidelines for having an efficient process using a fully synthetic human single-domain antibody (sdAb) phage display library. Critical milestones for success focused on library quality control (QC) assessments, evaluation of specific biopanning outputs, and construct designs that enabled efficient transition to mammalian expression. The synthetic VHO libraries produced epitope diversity better than an immunized sourced library with candidates possessing nM potencies and monodispersity > 90% via SEC.
Synthetic human scaffold sdAb phage display libraries was constructed, biopanned, and selected candidates that could be directly transitioned for mammalian expression. The diverse VHO sets of candidates produced from many targets easily provided opportunities to make a multi-specific biological compound. Both synthetic and immunized phage selection campaign results suggested that these technologies complemented each other to generate therapeutic candidates. Finally, we demonstrated how diverse data produced from a process that used VHO synthetic libraries could accelerate drug discovery.
背景/目的:癌症和自身免疫性疾病等疾病的复杂性推动了对独特的、靶向驱动疗法的需求。需要更广泛的武器库来开发基于生物制品的更好疗法,以提供更高效的抗体生成技术。抗体生成的关键参数是针对每个靶点尽可能多地产生候选多样性。
方法/结果:我们提出了使用完全合成的人单域抗体(sdAb)噬菌体展示文库的高效流程指南。成功的关键节点集中在文库质量控制(QC)评估、特定生物淘选结果的评估以及能够有效过渡到哺乳动物表达的构建体设计上。合成的VHO文库产生的表位多样性优于免疫来源的文库,通过尺寸排阻色谱法(SEC)筛选出的候选物具有纳摩尔级别的效力且单分散性>90%。
构建了合成人支架sdAb噬菌体展示文库,进行了生物淘选,并筛选出可直接过渡到哺乳动物表达的候选物。从多个靶点产生的多样的VHO候选物集很容易提供制造多特异性生物化合物的机会。合成和免疫噬菌体筛选活动的结果都表明,这些技术相互补充以产生治疗候选物。最后,我们展示了使用VHO合成文库的过程产生的多样数据如何加速药物发现。